{"id":741107,"date":"2023-03-20T06:48:40","date_gmt":"2023-03-20T10:48:40","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/syneos-health-collaborates-with-microsoft-to-accelerate-ai-across-the-clinical-to-commercial-continuum\/"},"modified":"2023-03-20T06:48:40","modified_gmt":"2023-03-20T10:48:40","slug":"syneos-health-collaborates-with-microsoft-to-accelerate-ai-across-the-clinical-to-commercial-continuum","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/syneos-health-collaborates-with-microsoft-to-accelerate-ai-across-the-clinical-to-commercial-continuum\/","title":{"rendered":"Syneos Health Collaborates with Microsoft to Accelerate AI Across the Clinical to Commercial Continuum"},"content":{"rendered":"<h2>\nCollaboration Leverages AI-ready Technology to Speed Asset Development and Optimize Performance<br \/>\n<\/h2>\n<div class=\"mw_release\">\n<p>MORRISVILLE, N.C., March  20, 2023  (GLOBE NEWSWIRE) &#8212; Syneos Health<sup>\u00ae<\/sup> (Nasdaq:SYNH), a leading fully integrated biopharmaceutical solutions organization, today announced a strategic multi-year agreement with Microsoft. Utilizing Microsoft Azure services, Syneos Health has developed an advanced analytics platform that enables agile deployment of machine learning (ML) supporting the analysis, design and execution of clinical trials and commercial programs worldwide.<\/p>\n<p>The multi-year agreement includes collaboration with Microsoft Research and leverages developments from OpenAI. Through this collaboration, Syneos Health will deliver technology and data solutions with Microsoft that accelerate clinical development and elevate commercial performance for biopharma customers.<\/p>\n<p>Based on this AI-enabled platform, Syneos Health is able to process and analyze data to fast-track timelines, optimize resource allocation and unlock clinical trial efficiencies. These capabilities will allow for superior site selection and reduced enrollment timelines to bring new treatments to patients faster.<\/p>\n<p>\u201cMicrosoft is the ideal technology partner for Syneos Health,\u201d said Michelle Keefe, CEO, Syneos Health. \u201cTheir clear industry leadership in AI and their pragmatic approach to improving healthcare outcomes for patients, science and industry is completely aligned with our value proposition. We look forward to a strong relationship for years to come \u2013 one that drives innovative solutions to accelerate our customers\u2019 success.\u201d<\/p>\n<p>\u201cWe are pleased to work with Syneos Health to bring our expertise in AI together with their solutions to help make a meaningful difference in the lives of patients,\u201d said Patty Obermaier, Vice President, U.S. Health and Life Sciences, Microsoft. \u201cSyneos Health\u2019s integration of Azure Synapse Analytics, Azure Data Factory, Azure SQL Database, and other Azure services, allows them to develop a platform that empowers biopharma customers to deliver therapies to patients faster.\u201d<\/p>\n<p>\n        <strong>About Syneos Health<\/strong>\n      <\/p>\n<p>Syneos Health<sup>\u00ae<\/sup> (Nasdaq:SYNH) is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities.\u00a0\u00a0<\/p>\n<p>We bring together a talented team of professionals, who work across more than 110 countries, with a deep understanding of patient and physician behaviors and market dynamics.\u00a0Together we share insights, use the latest technologies and apply advanced business practices to speed our customers\u2019 delivery of important therapies to patients.\u00a0<\/p>\n<p>Syneos Health supports a diverse, equitable and inclusive culture that cares for colleagues, customers, patients, communities and the environment.\u00a0\u00a0<\/p>\n<p>To learn more about how we are <strong>Shortening the distance from lab to life<\/strong><sup>\u00ae<\/sup>, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=tPEWqy7efTplt9j3Nbcdgfeva6V8R8BlW5OlFGBPXbzv7K0iyBF4zywpsWp15TbXOw8mS2fW7ne9XJqSNDYtHBkfiFwanv-QuLS-C2m8eWE=\" rel=\"nofollow noopener\" target=\"_blank\"><u>syneoshealth.com<\/u><\/a> or <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=8sgsWuGdOmSOL6jG6HAJJm7YbbsLoK7gjP4iBey8NlRpZGoDwBTH2UR3dzZZt1TEzXIfTGc1_6ZUo9IZE5z45Ei-QWuenMdMt8Vc7xMKUxFjwjrokJrIhr6pWpmOQjHr\" rel=\"nofollow noopener\" target=\"_blank\">subscribe to our podcast<\/a>.\u00a0\u00a0<\/p>\n<table style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td colspan=\"3\">\n            <strong>Syneos Health Contacts:<\/strong><br \/>\n            \n          <\/td>\n<\/tr>\n<tr>\n<td style=\"max-width:30%;width:30%;min-width:30%\">Investor Relations<br \/>Ronnie Speight<br \/>Senior Vice President, Investor Relations<br \/>+1 919 745 2745<br \/><a href=\"mailto:Investor.Relations@syneoshealth.com\" rel=\"nofollow noopener\" target=\"_blank\">Investor.Relations@syneoshealth.com<\/a>\u00a0<\/td>\n<td style=\"max-width:1%;width:1%;min-width:1%\">\u00a0<\/td>\n<td style=\"max-width:69%;width:69%;min-width:69%\">Press\/Media<br \/>Gary Gatyas<br \/>Executive Director, External Communications<br \/>+1 908 763 3428<br \/><a href=\"mailto:gary.gatyas@syneoshealth.com\" rel=\"nofollow noopener\" target=\"_blank\"><u>gary.gatyas@syneoshealth.com<\/u><\/a><\/td>\n<\/tr>\n<\/table>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc5MDc3NSM1NDY4NzYyIzIwMDQyNDk=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/OWZiMGE4MjctOTAxZC00ZDY3LWFkZGMtYjM0M2FkNjkxMDBiLTEwMTU4MjI=\/tiny\/Syneos-Health-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Collaboration Leverages AI-ready Technology to Speed Asset Development and Optimize Performance MORRISVILLE, N.C., March 20, 2023 (GLOBE NEWSWIRE) &#8212; Syneos Health\u00ae (Nasdaq:SYNH), a leading fully integrated biopharmaceutical solutions organization, today announced a strategic multi-year agreement with Microsoft. Utilizing Microsoft Azure services, Syneos Health has developed an advanced analytics platform that enables agile deployment of machine learning (ML) supporting the analysis, design and execution of clinical trials and commercial programs worldwide. The multi-year agreement includes collaboration with Microsoft Research and leverages developments from OpenAI. Through this collaboration, Syneos Health will deliver technology and data solutions with Microsoft that accelerate clinical development and elevate commercial performance for biopharma customers. Based on this AI-enabled platform, Syneos Health is able to process and analyze &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/syneos-health-collaborates-with-microsoft-to-accelerate-ai-across-the-clinical-to-commercial-continuum\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Syneos Health Collaborates with Microsoft to Accelerate AI Across the Clinical to Commercial Continuum&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-741107","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Syneos Health Collaborates with Microsoft to Accelerate AI Across the Clinical to Commercial Continuum - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/syneos-health-collaborates-with-microsoft-to-accelerate-ai-across-the-clinical-to-commercial-continuum\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Syneos Health Collaborates with Microsoft to Accelerate AI Across the Clinical to Commercial Continuum - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Collaboration Leverages AI-ready Technology to Speed Asset Development and Optimize Performance MORRISVILLE, N.C., March 20, 2023 (GLOBE NEWSWIRE) &#8212; Syneos Health\u00ae (Nasdaq:SYNH), a leading fully integrated biopharmaceutical solutions organization, today announced a strategic multi-year agreement with Microsoft. Utilizing Microsoft Azure services, Syneos Health has developed an advanced analytics platform that enables agile deployment of machine learning (ML) supporting the analysis, design and execution of clinical trials and commercial programs worldwide. The multi-year agreement includes collaboration with Microsoft Research and leverages developments from OpenAI. Through this collaboration, Syneos Health will deliver technology and data solutions with Microsoft that accelerate clinical development and elevate commercial performance for biopharma customers. Based on this AI-enabled platform, Syneos Health is able to process and analyze &hellip; Continue reading &quot;Syneos Health Collaborates with Microsoft to Accelerate AI Across the Clinical to Commercial Continuum&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/syneos-health-collaborates-with-microsoft-to-accelerate-ai-across-the-clinical-to-commercial-continuum\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-20T10:48:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc5MDc3NSM1NDY4NzYyIzIwMDQyNDk=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/syneos-health-collaborates-with-microsoft-to-accelerate-ai-across-the-clinical-to-commercial-continuum\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/syneos-health-collaborates-with-microsoft-to-accelerate-ai-across-the-clinical-to-commercial-continuum\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Syneos Health Collaborates with Microsoft to Accelerate AI Across the Clinical to Commercial Continuum\",\"datePublished\":\"2023-03-20T10:48:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/syneos-health-collaborates-with-microsoft-to-accelerate-ai-across-the-clinical-to-commercial-continuum\\\/\"},\"wordCount\":452,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/syneos-health-collaborates-with-microsoft-to-accelerate-ai-across-the-clinical-to-commercial-continuum\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc5MDc3NSM1NDY4NzYyIzIwMDQyNDk=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/syneos-health-collaborates-with-microsoft-to-accelerate-ai-across-the-clinical-to-commercial-continuum\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/syneos-health-collaborates-with-microsoft-to-accelerate-ai-across-the-clinical-to-commercial-continuum\\\/\",\"name\":\"Syneos Health Collaborates with Microsoft to Accelerate AI Across the Clinical to Commercial Continuum - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/syneos-health-collaborates-with-microsoft-to-accelerate-ai-across-the-clinical-to-commercial-continuum\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/syneos-health-collaborates-with-microsoft-to-accelerate-ai-across-the-clinical-to-commercial-continuum\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc5MDc3NSM1NDY4NzYyIzIwMDQyNDk=\",\"datePublished\":\"2023-03-20T10:48:40+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/syneos-health-collaborates-with-microsoft-to-accelerate-ai-across-the-clinical-to-commercial-continuum\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/syneos-health-collaborates-with-microsoft-to-accelerate-ai-across-the-clinical-to-commercial-continuum\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/syneos-health-collaborates-with-microsoft-to-accelerate-ai-across-the-clinical-to-commercial-continuum\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc5MDc3NSM1NDY4NzYyIzIwMDQyNDk=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc5MDc3NSM1NDY4NzYyIzIwMDQyNDk=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/syneos-health-collaborates-with-microsoft-to-accelerate-ai-across-the-clinical-to-commercial-continuum\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Syneos Health Collaborates with Microsoft to Accelerate AI Across the Clinical to Commercial Continuum\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Syneos Health Collaborates with Microsoft to Accelerate AI Across the Clinical to Commercial Continuum - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/syneos-health-collaborates-with-microsoft-to-accelerate-ai-across-the-clinical-to-commercial-continuum\/","og_locale":"en_US","og_type":"article","og_title":"Syneos Health Collaborates with Microsoft to Accelerate AI Across the Clinical to Commercial Continuum - Market Newsdesk","og_description":"Collaboration Leverages AI-ready Technology to Speed Asset Development and Optimize Performance MORRISVILLE, N.C., March 20, 2023 (GLOBE NEWSWIRE) &#8212; Syneos Health\u00ae (Nasdaq:SYNH), a leading fully integrated biopharmaceutical solutions organization, today announced a strategic multi-year agreement with Microsoft. Utilizing Microsoft Azure services, Syneos Health has developed an advanced analytics platform that enables agile deployment of machine learning (ML) supporting the analysis, design and execution of clinical trials and commercial programs worldwide. The multi-year agreement includes collaboration with Microsoft Research and leverages developments from OpenAI. Through this collaboration, Syneos Health will deliver technology and data solutions with Microsoft that accelerate clinical development and elevate commercial performance for biopharma customers. Based on this AI-enabled platform, Syneos Health is able to process and analyze &hellip; Continue reading \"Syneos Health Collaborates with Microsoft to Accelerate AI Across the Clinical to Commercial Continuum\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/syneos-health-collaborates-with-microsoft-to-accelerate-ai-across-the-clinical-to-commercial-continuum\/","og_site_name":"Market Newsdesk","article_published_time":"2023-03-20T10:48:40+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc5MDc3NSM1NDY4NzYyIzIwMDQyNDk=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/syneos-health-collaborates-with-microsoft-to-accelerate-ai-across-the-clinical-to-commercial-continuum\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/syneos-health-collaborates-with-microsoft-to-accelerate-ai-across-the-clinical-to-commercial-continuum\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Syneos Health Collaborates with Microsoft to Accelerate AI Across the Clinical to Commercial Continuum","datePublished":"2023-03-20T10:48:40+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/syneos-health-collaborates-with-microsoft-to-accelerate-ai-across-the-clinical-to-commercial-continuum\/"},"wordCount":452,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/syneos-health-collaborates-with-microsoft-to-accelerate-ai-across-the-clinical-to-commercial-continuum\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc5MDc3NSM1NDY4NzYyIzIwMDQyNDk=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/syneos-health-collaborates-with-microsoft-to-accelerate-ai-across-the-clinical-to-commercial-continuum\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/syneos-health-collaborates-with-microsoft-to-accelerate-ai-across-the-clinical-to-commercial-continuum\/","name":"Syneos Health Collaborates with Microsoft to Accelerate AI Across the Clinical to Commercial Continuum - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/syneos-health-collaborates-with-microsoft-to-accelerate-ai-across-the-clinical-to-commercial-continuum\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/syneos-health-collaborates-with-microsoft-to-accelerate-ai-across-the-clinical-to-commercial-continuum\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc5MDc3NSM1NDY4NzYyIzIwMDQyNDk=","datePublished":"2023-03-20T10:48:40+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/syneos-health-collaborates-with-microsoft-to-accelerate-ai-across-the-clinical-to-commercial-continuum\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/syneos-health-collaborates-with-microsoft-to-accelerate-ai-across-the-clinical-to-commercial-continuum\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/syneos-health-collaborates-with-microsoft-to-accelerate-ai-across-the-clinical-to-commercial-continuum\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc5MDc3NSM1NDY4NzYyIzIwMDQyNDk=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc5MDc3NSM1NDY4NzYyIzIwMDQyNDk="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/syneos-health-collaborates-with-microsoft-to-accelerate-ai-across-the-clinical-to-commercial-continuum\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Syneos Health Collaborates with Microsoft to Accelerate AI Across the Clinical to Commercial Continuum"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/741107","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=741107"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/741107\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=741107"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=741107"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=741107"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}